Sage Journals: Discover world-class research

Retricted access

Research article

First published 2008-10

Bevacizumab: A Treatment Option for Recurrent Glioblastoma Multiforme

Larry W Buie, John M Valgus

Annals of Pharmacotherapy

Free access

Research article

First published 2018-3

Recurrence of glioblastoma is associated with elevated microvascular transit time heterogeneity and increased hypoxia

Andreas Stadlbauer, Kim Mouridsen, Arnd Doerfler [...]

Journal of Cerebral Blood Flow & Metabolism

Retricted access

Research article

First published 2015-3

Management of Patients with Recurrent Glioblastoma using Hypofractionated Stereotactic Radiotherapy

Ferrat Dincoglan, Murat Beyzadeoglu, Omer Sager [...]

Tumori Journal

Retricted access

Research article

First published 2013-10

Glioblastoma Multiforme: Relationship to Subventricular Zone and Recurrence

Margareth Kimura, Yeuh Lee, Ryan Miller [...]

The Neuroradiology Journal

Free access

Research article

First published 2011-6

Re-irradiation with Radiosurgery for Recurrent Glioblastoma Multiforme

J. A. Torok, R. E. Wegner, A. H. Mintz [...]

Technology in Cancer Research & Treatment

Retricted access

Research article

First published 2013-09

Bevacizumab Alone at 5 mg/kg in an Every-3-Week Schedule for Patients with Recurrent Glioblastomas: A Single Center Experience

Gentian Kaloshi, Gramoz Brace, Arben Rroji [...]

Tumori Journal

Free access

Research article

First published 2020-3

Physiologic MR imaging of the tumor microenvironment revealed switching of metabolic phenotype upon recurrence of glioblastoma in humans

Andreas Stadlbauer, Stefan Oberndorfer, Max Zimmermann [...]

Journal of Cerebral Blood Flow & Metabolism

Retricted access

Research article

First published 2015-1

The Added Value of Bevacizumab Concomitantly Administered with Carboplatin versus Carboplatin Alone in Patients with Recurrent Glioblastomas

Gentian Kaloshi, Pavllo Diamandi, Bujar Cakani [...]

Tumori Journal

Open access

Review article

First published 2011

Bevacizumab for the Treatment of Recurrent Glioblastoma

Marc C. Chamberlain

Clinical Medicine Insights: Oncology

Retricted access

Research article

First published 2008-6

Peritumoral Apparent Diffusion Coefficient as a Metric of Response in Patients with Recurrent Glioblastoma Multiforme Treated with Bevacizumab and Irinotecan

J.B. Andre, S. Lu, K. Spearman [...]

The Neuroradiology Journal

Search results